http://www.onclive.com/onclive-tv/dr-pant-on-the-thirdline-setting-for-metastatic-crc
Dr. Pant on the Third-Line Setting for Metastatic CRC

Shubham Pant, MD



Shubham Pant, MD, associate professor, The University of Texas MD Anderson Cancer Center, discusses the third-line setting for patients with metastatic colorectal cancer (CRC).

According to Pant, there are not many options for patients with CRC in the third-line setting. Currently, regorafenib (Stivarga) and TAS-102 are the only options for this setting.

Next-generation sequencing is important to determine targets for treatment, explains Pant.
 
Printer Printing...